Does Self-Efficacy at the Start of Treatment Influence Treatment Outcome in Patients With EDs?
1 other identifier
observational
50
1 country
1
Brief Summary
The goal of this clinical trial is to contribute to the improvement of treatment for eating disorders, by identifying factors that might positively affect treatment outcome. The main questions it aims to answer are:
- 1.Do higher levels of self-efficacy positively predict a more positive treatment outcome?
- 2.Does self-efficacy in itself improve during treatment?
- 3.Do autonomous motivation, self-esteem and self-efficacy correlate?
- 4.Receive their treatment as usual.
- 5.fill in questionnaires at the start of treatment, session 4 and end of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2023
CompletedFirst Submitted
Initial submission to the registry
November 27, 2024
CompletedFirst Posted
Study publicly available on registry
January 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 23, 2025
January 1, 2025
2.1 years
November 27, 2024
January 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
treatment outcome
Eating Disorder-15 (ED-15) is a self-report questionnaire used to measure session-by-session change in eating pathology as part of the CBT-T protocol. All items are positively scored from 0-6, with higher scores reflecting higher levels of eating disorder pathology.
CBT-T is a weekly, ten-session treatment. The ED-15 will be adminstered at the start of the first treatment session, at session 4 and at the end of treatment (session 10).: * week 1 * week 4 * week 10
Secondary Outcomes (2)
General Self-efficacy
CBT-T is a weekly, ten-session treatment. The GSES will be adminstered at at the start of the first treatment session , at session 4 and at the end of treatment (session 10): * week 1 * week 4 * week 10
Coping Self-efficacy
CBT-T is a weekly, ten-session treatment. The CSES will be adminstered at the start of the first treatment session , at session 4 and at the end of treatment (session 10): * week 1 * week 4 * week 10
Other Outcomes (3)
Autonomous motivation
CBT-T is a weekly, ten-session treatment. The ACMTQ will be adminstered at the start of the first treatment session: *week 1
Self-esteem
CBT-T is a weekly, ten-session treatment. The RSES will be adminstered at the start of the first treatment session: *week 1
Motivation
CBT-T is a weekly, ten-session treatment. The Motivational Ruler will be adminstered at the start of the first treatment session: * week 1.
Interventions
cognitive behavioral therapy-ten :
Eligibility Criteria
(adult) Patients treated for eatingdisorders with CBT-T at Altrecht Eating Disorders Rintveld or at Co-eur.
You may qualify if:
- Participants must be 18 years or older
- Having an eating disorder diagnosed according to the Diagnostic Statistical Manual (DSM-5)
- Starting CBT-T treatment
You may not qualify if:
- Intellectual disability according to the Diagnostic Statistical Manual (DSM-5) or an IQ below 80
- Inability to speak or read Dutch
- Patients treated under a legal act
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Altrechtlead
Study Sites (1)
Altrecht Eatings Disorders Rintveld
Zeist, Utrecht, 3705WE, Netherlands
Related Publications (17)
Denison-Day J, Appleton KM, Newell C, Muir S. Improving motivation to change amongst individuals with eating disorders: A systematic review. Int J Eat Disord. 2018 Sep;51(9):1033-1050. doi: 10.1002/eat.22945. Epub 2018 Sep 6.
PMID: 30189116BACKGROUNDWaller G, Tatham M, Turner H, Mountford VA, Bennetts A, Bramwell K, Dodd J, Ingram L. A 10-session cognitive-behavioral therapy (CBT-T) for eating disorders: Outcomes from a case series of nonunderweight adult patients. Int J Eat Disord. 2018 Mar;51(3):262-269. doi: 10.1002/eat.22837. Epub 2018 Feb 8.
PMID: 29417603BACKGROUNDTatham M, Turner H, Mountford VA, Tritt A, Dyas R, Waller G. Development, psychometric properties and preliminary clinical validation of a brief, session-by-session measure of eating disorder cognitions and behaviors: The ED-15. Int J Eat Disord. 2015 Nov;48(7):1005-15. doi: 10.1002/eat.22430. Epub 2015 May 26.
PMID: 26011054BACKGROUNDSteiger H, Sansfacon J, Thaler L, Leonard N, Cottier D, Kahan E, Fletcher E, Rossi E, Israel M, Gauvin L. Autonomy support and autonomous motivation in the outpatient treatment of adults with an eating disorder. Int J Eat Disord. 2017 Sep;50(9):1058-1066. doi: 10.1002/eat.22734. Epub 2017 Jun 14.
PMID: 28842966BACKGROUNDSteele AL, Bergin J, Wade TD. Self-efficacy as a robust predictor of outcome in guided self-help treatment for broadly defined bulimia nervosa. Int J Eat Disord. 2011 Jul;44(5):389-96. doi: 10.1002/eat.20830. Epub 2010 Aug 18.
PMID: 20721895BACKGROUNDSansfacon J, Fletcher E, Zuroff DC, Schmitz N, Miller A, Israel M, Steiger H. Psychometric properties of the "Autonomous and Controlled Motivation for Treatment Questionnaire" in women with eating disorders. Eur Eat Disord Rev. 2019 May;27(3):306-314. doi: 10.1002/erv.2656. Epub 2018 Nov 12.
PMID: 30417472BACKGROUNDMansour S, Bruce KR, Steiger H, Zuroff DC, Horowitz S, Anestin AS, Sycz L. Autonomous motivation: a predictor of treatment outcome in bulimia-spectrum eating disorders. Eur Eat Disord Rev. 2012 May;20(3):e116-22. doi: 10.1002/erv.2154. Epub 2012 Feb 7.
PMID: 22311824BACKGROUNDLinardon J, de la Piedad Garcia X, Brennan L. Predictors, Moderators, and Mediators of Treatment Outcome Following Manualised Cognitive-Behavioural Therapy for Eating Disorders: A Systematic Review. Eur Eat Disord Rev. 2017 Jan;25(1):3-12. doi: 10.1002/erv.2492. Epub 2016 Nov 16.
PMID: 27862611BACKGROUNDHasking P, Boyes M, Greves S. Self-efficacy and emotionally dysregulated behaviour: An exploratory test of the role of emotion regulatory and behaviour-specific beliefs. Psychiatry Res. 2018 Dec;270:335-340. doi: 10.1016/j.psychres.2018.09.045. Epub 2018 Sep 20.
PMID: 30292086BACKGROUNDHamadi L, Holliday J. Moderators and mediators of outcome in treatments for anorexia nervosa and bulimia nervosa in adolescents: A systematic review of randomized controlled trials. Int J Eat Disord. 2020 Jan;53(1):3-19. doi: 10.1002/eat.23159. Epub 2019 Sep 11.
PMID: 31506978BACKGROUNDEisenberg MH, Lipsky LM, Dempster KW, Liu A, Nansel TR. I Should but I Can't: Controlled Motivation and Self-Efficacy Are Related to Disordered Eating Behaviors in Adolescents With Type 1 Diabetes. J Adolesc Health. 2016 Nov;59(5):537-542. doi: 10.1016/j.jadohealth.2016.06.008. Epub 2016 Aug 23.
PMID: 27567063BACKGROUNDClarke J, Proudfoot J, Birch MR, Whitton AE, Parker G, Manicavasagar V, Harrison V, Christensen H, Hadzi-Pavlovic D. Effects of mental health self-efficacy on outcomes of a mobile phone and web intervention for mild-to-moderate depression, anxiety and stress: secondary analysis of a randomised controlled trial. BMC Psychiatry. 2014 Sep 26;14:272. doi: 10.1186/s12888-014-0272-1.
PMID: 25252853BACKGROUNDChesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. A validity and reliability study of the coping self-efficacy scale. Br J Health Psychol. 2006 Sep;11(Pt 3):421-37. doi: 10.1348/135910705X53155.
PMID: 16870053BACKGROUNDChang PGRY, Delgadillo J, Waller G. Early response to psychological treatment for eating disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2021 Jun;86:102032. doi: 10.1016/j.cpr.2021.102032. Epub 2021 Apr 18.
PMID: 33915335BACKGROUNDBruijniks SJ, Bosmans J, Peeters FP, Hollon SD, van Oppen P, van den Boogaard M, Dingemanse P, Cuijpers P, Arntz A, Franx G, Huibers MJ. Frequency and change mechanisms of psychotherapy among depressed patients: study protocol for a multicenter randomized trial comparing twice-weekly versus once-weekly sessions of CBT and IPT. BMC Psychiatry. 2015 Jun 30;15:137. doi: 10.1186/s12888-015-0532-8.
PMID: 26122891BACKGROUNDBosscher RJ, Smit JH. Confirmatory factor analysis of the General Self-Efficacy Scale. Behav Res Ther. 1998 Mar;36(3):339-43. doi: 10.1016/s0005-7967(98)00025-4.
PMID: 9642852BACKGROUNDBardone-Cone AM, Thompson KA, Miller AJ. The self and eating disorders. J Pers. 2020 Feb;88(1):59-75. doi: 10.1111/jopy.12448. Epub 2018 Dec 30.
PMID: 30506587BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical psychologist; Lead Expert Eatingdisorders Altrecht
Study Record Dates
First Submitted
November 27, 2024
First Posted
January 23, 2025
Study Start
March 28, 2023
Primary Completion
April 30, 2025
Study Completion
December 1, 2025
Last Updated
January 23, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- for the next 15 years
- Access Criteria
- information can be obtained by contacten the researchers.
data will be profided in case of a specific request. Data will be stored anonymously in a database on a special drive for scientific research at Altrecht. Researchers will act according to the Declaration of Helsinki, version 59th WMA General Assembly, October 2008. All study data will be stored in a coded way and the key-to-the-name information will be stored in a separate file which will only be accessible to researchers directly involved in the study. The data will be handled confidently and anonymously and will be stored for at least 15 years, in line with the article 454 section 3 from "Wet op de Geneeskundige Behandelingsovereenkomst - WGBO". Only the researchers who are directly involved in this project will have access to the data. The data will be described at group level. All data will be handled and described within the Altrecht workspace.